Effect of Common<i>CYP3A4</i>and<i>CYP3A5</i>Variants on the Pharmacokinetics of the Cytochrome<i>P</i>450 3A Phenotyping Probe Midazolam in Cancer Patients - Concepedia

Concepedia

Publication | Open Access

Effect of Common<i>CYP3A4</i>and<i>CYP3A5</i>Variants on the Pharmacokinetics of the Cytochrome<i>P</i>450 3A Phenotyping Probe Midazolam in Cancer Patients

DOI Full Paper Access

71

Citations

32

References

2005

Year

Erin R. Lepper, Sharyn D. Baker, Matt Permenter, Nicole Ries, Ron H. N. van Schaik, Paul W. Schenk, Douglas K. Price, Danielle Ahn, Nicola F. Smith, George Cusatis,

Clinical Cancer Research

Abstract

The studied genetic variants in CYP3A4 and CYP3A5 are unlikely to have an important functional significance to phenotypic CYP3A activity in patients with cancer.

References

	Year	Citations

Page 1